Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962

J Urol. 2009 Nov;182(5):2531-2; discussion 2532-4. doi: 10.1016/j.juro.2009.07.053. Epub 2009 Sep 18.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Follow-Up Studies
  • Humans
  • Male
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Radiotherapy, Adjuvant
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Survival Rate
  • Time Factors